CARBO Ceramics Inc. (CRR) Reaches $8.91 Formed H&S; CORIX BIOSCIENCE (CXBS) Shorts Raised By 68%




May 7, 2018 – By Clifton Ray

CARBO Ceramics Inc. (NYSE:CRR) Logo

CARBO Ceramics Inc. (CRR) formed H&S with $8.46 target or 5.00% below today’s $8.91 share price. CARBO Ceramics Inc. (CRR) has $244.25M valuation. The stock increased 0.11% or $0.01 during the last trading session, reaching $8.91. About 427,787 shares traded. CARBO Ceramics Inc. (NYSE:CRR) has declined 36.43% since May 7, 2017 and is downtrending. It has underperformed by 47.98% the S&P500.

CORIX BIOSCIENCE INC (OTCMKTS:CXBS) had an increase of 68% in short interest. CXBS’s SI was 4,200 shares in May as released by FINRA. Its up 68% from 2,500 shares previously. It closed at $0.3 lastly. It is down 0.00% since May 7, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 11 analysts covering Carbo Ceramics Inc. (NYSE:CRR), 2 have Buy rating, 1 Sell and 8 Hold. Therefore 18% are positive. Carbo Ceramics Inc. has $32 highest and $700 lowest target. $14.93’s average target is 67.56% above currents $8.91 stock price. Carbo Ceramics Inc. had 26 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was maintained by Cowen & Co with “Market Perform” on Wednesday, May 10. The stock of CARBO Ceramics Inc. (NYSE:CRR) earned “In-Line” rating by Evercore on Monday, January 29. Cowen & Co maintained CARBO Ceramics Inc. (NYSE:CRR) rating on Monday, February 6. Cowen & Co has “Market Perform” rating and $15 target. The company was maintained on Monday, April 2 by Piper Jaffray. The stock of CARBO Ceramics Inc. (NYSE:CRR) has “Hold” rating given on Wednesday, August 30 by Cowen & Co. The firm has “Sector Perform” rating given on Thursday, September 10 by Howard Weil. The firm earned “Hold” rating on Thursday, March 15 by Cowen & Co. Howard Weil maintained it with “Sector Perform” rating and $15 target in Tuesday, June 7 report. The firm has “Neutral” rating by Goldman Sachs given on Friday, December 16. Piper Jaffray maintained it with “Hold” rating and $9.2500 target in Thursday, July 27 report.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.59, from 1.5 in 2017Q3. It worsened, as 15 investors sold CARBO Ceramics Inc. shares while 40 reduced holdings. 17 funds opened positions while 33 raised stakes. 18.69 million shares or 6.27% less from 19.94 million shares in 2017Q3 were reported. Susquehanna Group Llp has invested 0% of its portfolio in CARBO Ceramics Inc. (NYSE:CRR). State Of Alaska Department Of Revenue reported 4,382 shares stake. Assetmark invested in 13 shares. Price T Rowe Assocs Md holds 0% or 27,161 shares. Arrowstreet Partnership holds 203,260 shares or 0% of its portfolio. Moreover, Sg Americas Limited Liability Co has 0.01% invested in CARBO Ceramics Inc. (NYSE:CRR). Royal Bank Of Canada has invested 0% in CARBO Ceramics Inc. (NYSE:CRR). State Street, a Massachusetts-based fund reported 524,407 shares. Morgan Stanley accumulated 122,214 shares. Laurion Lp holds 0% of its portfolio in CARBO Ceramics Inc. (NYSE:CRR) for 37,797 shares. Great West Life Assurance Can reported 0% stake. Goldman Sachs Gru owns 0% invested in CARBO Ceramics Inc. (NYSE:CRR) for 158,443 shares. Disciplined Growth Inc Mn invested in 242,078 shares or 0.05% of the stock. Capstone Ltd invested 0.01% of its portfolio in CARBO Ceramics Inc. (NYSE:CRR). Incorporated holds 18,135 shares.

Since May 1, 2018, it had 2 insider purchases, and 0 sales for $111,570 activity. Kolstad Gary A also bought $26,670 worth of CARBO Ceramics Inc. (NYSE:CRR) shares.

Corix Bioscience, Inc. provides cannabidiol oil for various medicinal purposes. The company has market cap of $7.46 million. It engages in the planting, harvesting, and extraction of CBD oil from the industrial Hemp plant. It currently has negative earnings. The firm was formerly known as American Housing Income Trust, Inc. and changed its name to Corix Bioscience, Inc. in June 2017.

CARBO Ceramics Inc. (NYSE:CRR) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.




Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *